A multicenter prospective study of risk factors associated with medication-related osteonecrosis of the jaw after tooth extraction in cancer patients receiving intravenous bisphosphonate or denosumab therapy
Not Applicable
- Conditions
- Cancer patients receiving high-dose bone-modifying agents who tooth extraction were performed
- Registration Number
- JPRN-UMIN000033743
- Lead Sponsor
- Kobe University Graduate School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Not provided
Exclusion Criteria
Patients who reject to participate this study
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The incident rate of MRONJ at 2 months after tooth extraction
- Secondary Outcome Measures
Name Time Method